当前位置:首页 - 行情中心 - 海正药业(600267) - 财务分析 - 资产负债表

海正药业

(600267)

  

流通市值:102.68亿  总市值:102.74亿
流通股本:11.98亿   总股本:11.99亿

资产负债表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
流动资产:
货币资金1,483,984,960.121,442,197,604.61,568,730,864.921,586,627,072.09
应收票据及应收账款1,942,119,157.572,044,706,924.31,959,816,820.191,917,092,913.47
应收账款1,942,119,157.572,044,706,924.31,959,816,820.191,917,092,913.47
应收款项融资132,241,322.53227,188,434.93256,314,372.48148,960,375.05
预付款项156,936,256.26204,582,373.04242,419,169.84214,087,488.77
其他应收款合计280,916,724.09221,033,417.97203,481,922.95203,509,845.86
存货1,728,928,686.511,754,733,001.211,830,044,519.421,956,874,088.91
其他流动资产59,072,551.46214,184,001.54313,251,313.16331,381,277.99
流动资产平衡项目0000
流动资产合计5,784,199,658.546,108,625,757.596,374,058,982.966,358,825,683.34
非流动资产:
长期股权投资1,456,244,097.971,433,097,748.891,438,706,067.261,394,383,938.17
其他非流动金融资产20,029,400.7120,085,778.4420,180,809.9220,202,618.75
投资性房地产95,205,557.8396,788,630.2998,371,702.7799,242,413.21
固定资产7,256,619,801.677,431,470,444.657,655,656,964.957,524,366,387.82
在建工程385,368,209.94387,205,124.28360,957,646.81688,388,546.37
使用权资产66,372,707.9339,660,930.9240,968,998.4838,909,296.73
无形资产962,677,449.531,038,044,223.251,023,299,252.971,073,306,446.58
开发支出46,210,684.26168,184,455.8167,698,393.88167,698,393.88
长期待摊费用6,118,549.446,859,893.967,659,391.68,562,528.45
递延所得税资产152,797,698.41174,483,743.63183,034,168.2179,618,106.3
其他非流动资产25,152,582.1521,032,582.1559,541,574.4159,777,343.12
非流动资产平衡项目0000
非流动资产合计10,472,796,739.8410,816,913,556.2611,056,074,971.2511,254,456,019.38
资产平衡项目0000
资产总计16,256,996,398.3816,925,539,313.8517,430,133,954.2117,613,281,702.72
流动负债:
短期借款2,477,072,444.872,651,071,767.092,643,465,153.232,157,057,650.45
应付票据及应付账款1,003,663,840.91,182,920,204.761,381,192,952.21,314,186,937.94
其中:应付票据294,483,783.29429,636,453.6518,196,029.64445,771,008.49
应付账款709,180,057.61753,283,751.16862,996,922.56868,415,929.45
预收款项40,00040,00040,00040,000
合同负债116,278,133.65104,515,791.98109,484,904.33106,456,225.75
应付职工薪酬393,529,103.72330,591,982.93258,679,905.71353,804,454.13
应交税费142,887,845.35121,678,662.8796,869,443.12140,943,456.7
其他应付款合计1,223,823,931.361,464,937,304.121,322,386,155.251,367,125,474.7
一年内到期的非流动负债883,108,109.48847,644,099.481,088,528,923.571,137,391,284.57
其他流动负债6,886,311.98308,716,682.96308,472,663.666,609,640.09
流动负债平衡项目0000
流动负债合计6,247,289,721.317,012,116,496.197,209,120,101.076,583,615,124.33
非流动负债:
长期借款1,270,721,861.821,316,962,606.261,277,915,804.281,117,701,320.1
应付债券--337,721,451.431,250,731,821.14
租赁负债54,409,586.8934,822,494.8734,037,764.5629,147,195.14
预计负债--74,080,00074,080,000
递延收益164,767,683.73174,476,389178,840,801.24185,963,041.66
递延所得税负债24,251,961.9324,131,209.9528,553,091.7822,629,527.15
非流动负债平衡项目0000
非流动负债合计1,514,151,094.371,550,392,700.081,931,148,913.292,680,252,905.19
负债平衡项目0000
负债合计7,761,440,815.688,562,509,196.279,140,269,014.369,263,868,029.52
所有者权益(或股东权益):
实收资本(或股本)1,207,873,7161,207,873,7161,207,873,7161,207,873,677
其他权益工具--91,031,823.7340,904,257.55
资本公积4,357,457,655.834,355,488,869.684,349,367,057.014,345,836,408.57
减:库存股375,597,818.76429,314,537.46400,034,842.71341,153,462.07
其他综合收益11,659,348.8411,088,867.611,454,404.212,171,714.51
盈余公积554,122,288.28554,122,288.28554,122,288.28554,122,288.28
未分配利润2,497,532,654.512,417,461,062.82,230,750,966.921,982,219,678.83
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计8,253,047,844.78,116,720,266.98,044,565,413.48,101,974,562.67
少数股东权益242,507,738246,309,850.68245,299,526.45247,439,110.53
股东权益平衡项目0000
股东权益合计8,495,555,582.78,363,030,117.588,289,864,939.858,349,413,673.2
负债和股东权益合计16,256,996,398.3816,925,539,313.8517,430,133,954.2117,613,281,702.72
公告日期2024-10-312024-08-202024-04-302024-04-30
审计意见(境内)保留意见
TOP↑